List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 25 studies with search of: Open Studies | "Leishmaniasis"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Conditions: Leishmaniasis;   Leishmaniasis, Mucocutaneous
Intervention: Drug: Miltefosine
2 Recruiting Low Antimonial Dosage in American Mucosal Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Mucocutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
3 Recruiting Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
Conditions: Leishmaniasis;   Cutaneous Leishmaniasis
Interventions: Drug: pentavalent antimony;   Procedure: cryotherapy;   Drug: placebo cream
4 Recruiting Miltefosine to Treat Mucocutaneous Leishmaniasis
Conditions: Leishmaniasis, Mucocutaneous;   Cutaneous Leishmaniasis
Intervention: Drug: miltefosine
5 Unknown † Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Conditions: Leishmaniasis, Cutaneous;   Leishmaniasis, Mucocutaneous
Intervention: Drug: sodium stibogluconate (Pentostam)
6 Not yet recruiting SCH708980 With and Without AmBisome for Visceral Leishmaniasis
Conditions: Leishmaniasis;   IL-10;   Immunotherapy
Interventions: Drug: SCH708980 Anti-IL-10 monoclonal;   Drug: AmBisome
7 Recruiting Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Pentoxifylline;   Drug: Placebo
8 Not yet recruiting Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: meglumine antimonate;   Drug: Placebo;   Drug: Pentoxifylline
9 Recruiting Comparison of Low and High Antimonial Dosage in American Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
10 Recruiting Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: N-metil glucamine;   Drug: Azithromycin
11 Not yet recruiting Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: AMBISOME
12 Recruiting Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
Condition: Visceral Leishmaniasis
Interventions: Drug: Antimoniate of N-methylglucamine;   Drug: amphotericin B deoxycholate;   Drug: Liposomal amphotericin B
13 Recruiting Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Liposomal meglumine antimoniate (Glucantime);   Drug: Liposomal meglumine antimoniate;   Drug: Liposomal Paromomycin;   Drug: Placebo
14 Unknown † Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
Conditions: Visceral Leishmaniasis;   Immune Response;   Treatment
Interventions: Drug: N-acetylcysteine;   Drug: Pentavalent antimonial
15 Recruiting Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: Sodium Stibogluconate (SSG)
16 Recruiting Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: WR 279,396
17 Recruiting Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B;   Drug: liposomal amphotericin B + miltefosine;   Drug: liposomal amphotericin B + paromomycin;   Drug: Miltefosine + Paromomycin
18 Recruiting Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
Condition: Primary Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B (AmBisome®) and sodium stibogluconate;   Drug: Liposomal amphotericin B + miltefosine;   Drug: Miltefosine
19 Available Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Intervention: Device: Heat pack conduction-heat therapy
20 Recruiting Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
Conditions: Visceral Leishmaniosis;   HIV-infection/Aids
Intervention: Drug: Pentamidine

Previous Page Studies Shown (1-20) Next Page (21-25)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services